Decision | Khurana and Khurana

The Glivec saga in India is finally over

As it has been widely covered by media in and outside India, it is no new news to pharmaceutical and patent fraternity that Novartis has lost about 7 year long legal battle to secure a patent protection for its invention on beta crystalline form of imatinib mesylate in India. A 112 page long Supreme Court judgement … Continue reading

AI
Air Pollution
Arbitration
Asia
Automobile
Bangladesh
Banking
- RBI
Biodiversity
Biological Inventions
bLAWgathon
Brand Valuation
Business
Celebrity Rights
Company Act
Company Law
Competition Law
Constitutional Law
Consumer Law
Consumer Protection Authority
Copyright
- Music
Copyright Infringement
Copyright Litigation
Corporate Law
Counterfeiting
Covid
CRI Guidelines 2025
Cyber Law
Cybersquatting
Design
Design Registration in Noida
Digital Media
Digital Right Management
Dispute
Doping
Educational Conferences/ Seminar
Environment Law Practice
ESIC Act
EX-Parte
Farmer Right
Fashion Law
FDI
FERs
Foreign filing license
Foreign Law
Gaming Industry
GDPR
Geographical Indication (GI)
GIg Economy
Hi Tech Patent Commercialisation
Hi Tech Patent Litigation
IBC
India
Indian Contract Act
Indonesia
Intellectual Property
Intellectual Property Protection
IP Commercialization
IP Licensing
IP Litigation
IP Practice in India
IP registration in the USA
IPAB
IPAB Decisions
IT Act
IVF technique
Judiciary
Khadi Industries
labour Law
Legal Case
Legal Issues
- Data Protection
Lex Causae
Licensing
Live-in relationships
Lok Sabha Bill
Marriage Act
Maternity Benefit Act
Media & Entertainment Law
Mediation Act
Member of Parliament
Mergers & Acquisition
Myanmar
- Foreign
- Foreign Currency
NCLT
NEPAL
News & Updates
- Trade Secrets
Non-Disclosure Agreement
Online Gaming
Patent Act
Patent Application Drafting
Patent Commercialisation
Patent Description Writing
Patent Fess
Patent Filing
patent infringement
Patent Landscape
Patent Licensing
Patent Litigation
Patent Marketing
Patent Opposition
Patent prosecution in India
Patent Rule Amendment
Patents
- Patents Amendment
  - Patents Amendment
Personality rights
pharma
Pharma- biotech- Patent Commercialisation
Pharma/Biotech Patent Litigations
Pollution
Posh Act
Protection of SMEs
RERA
Sarfaesi Act
Section 3(D)
Signapore
Social Media
Sports Law
Stamp Duty
Stock Exchange
Surrogacy in India
TAX
Technology
Telecom Law
Telecommunications
Thailand
Trademark
Trademark Infringement
Trademark Litigation
Trademark Registration in Foreign
Traditional Knowledge
UAE
Uncategorized
USPTO
Vietnam
WIPO
Women Empower

Tag: Decision

The Glivec saga in India is finally over

Categories

Archives